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Abstract
Staphylococcus aureus colonization is a risk factor for invasive disease. There is a need to understand S. aureus colonization in infancy as the
burden of S. aureus infections in infants is high. We aimed to investigate the transmission of S. aureus between mothers and their newborns
during the ﬁrst year after delivery in an African setting. In a longitudinal cohort study, colonization of Gabonese mother–infant pairs was
assessed at delivery and after 1, 9 and 12 months. Swabs were taken from mothers (nares, mammillae) and infants (nares and throat).
Isolates were characterized and risk factors for colonization were assessed using a standardized questionnaire. We recruited 311 mothers
and 318 infants including seven sets of twins. Maternal and infant colonization rates declined synchronously following a peak after 1 month
at 40% (mothers) and 42% (infants). Maternal colonization was a risk factor for S. aureus carriage in infants. Based on spa typing, direct
mother-to-infant transmission was evident in 5.6%. Of all methicillin-resistant isolates (n = 9), 44.4% were related to the USA300 clone;
56.7% (n = 261) of all S. aureus carried Panton–Valentine leukocidin encoding genes. Direct mother-to-infant transmission was rare and
cannot explain the increase of carriage in infants within the ﬁrst month. A transmission from external sources is likely and challenges the
S. aureus infection control in newborns and infants in an African setting. The detection of USA300-related MRSA fuels the concern about
the spread of this clone in Central Africa.
Keywords: Africa, infancy, Staphylococcus aureus, transmission, USA300
Original Submission: 15 July 2013; Revised Submission: 28 August 2013; Accepted: 26 September 2013
Editor: G. Lina
Article published online: 18 November 2013
Clin Microbiol Infect 2014; 20: O390–O396
doi: 10.1111/1469-0691.12417
Corresponding author: F. Schaumburg, Institute of Medical
Microbiology, University Hospital M€unster, Domagkstrasse 10,
48149 M€unster, Germany
E-mail: frieder.schaumburg@ukmuenster.de
Introduction
Staphylococcus aureus is a major cause of superﬁcial and invasive
infections. Nasal colonization is a risk factor for infection and
the invasive strain is usually also the nasal carriage strain [1,2].
Methicillin-resistant Staphylococcus aureus (MRSA) is a challenge
for healthcare systems because of the limited therapeutic
options. An estimate of 11 478 deaths was attributed to MRSA
infections in the USA in 2010, which is comparable to the
mortality attributed to HIV/AIDS (15 529 deaths in the USA in
2010, http://www.cdc.gov).
The burden of S. aureus infections in infants is high.
Hospitalized infants under 1 year of age had the highest risk
of infection (OR = 5.64, 95% CI 5.55–5.73), the highest annual
incidence (452 cases per 100 000 infants of the general
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population) and the highest mortality (4.5%) compared with
children aged between 1 and 17 years in the USA [3]. Maternal
S. aureus carriage and breastfeeding were identiﬁed as risk
factors for early postnatal colonization of the infant [4,5]. From
53 to 80% of mother–newborn dyads were concomitantly
colonized and shared the same S. aureus type [6,7]. However,
concomitant colonization does not provide evidence of the
source of the isolate, which can only be assessed in longitudinal
observations and by genotyping of isolates [8].
Determinants of lifestyle habits of pregnant mothers living in
industrialized countries are different from those of mothers
living in developing regions in sub-Saharan Africa, which might
affect the colonization pattern in infancy for several reasons.
First, intermittent preventive treatment in pregnancy (IPTp)
with sulphadoxine-pyrimethamine is recommended in coun-
tries where malaria is endemic and showed anti-staphylococcal
activity in vitro [9]. Second, shared breastfeeding—when an
infant is breastfed by lactating mothers other than the
biological mother—occurs in up to 40% of infants in Central
Africa and might inﬂuence the S. aureus colonization pattern
[10]. Third, crowded living conditions, high temperatures and
humidity might increase the transmission of S. aureus [11].
To analyse the colonization among mothers and their
infants in an African setting, we performed a longitudinal
carriage study in mothers and their infants in Gabon.
Materials and Methods
Ethics approval
Ethics approval was obtained from the ‘Comite d’Ethique
Regional Independant de Lambarene’, Gabon (CERIL 15-09).
Participating mothers provided written informed consent
before enrolment.
Study population
The longitudinal observational study was conducted at the
Ngounie Medical Research Centre in Fougamou, Gabon from
March 2010 to January 2013. The study was embedded in an
open-label randomized controlled trial investigating meﬂoqu-
ine in comparison to the standard sulphadoxine-pyrimeth-
amine for intermittent preventive treatment of malaria in
pregnancy (IPTp, MIPPAD (Malaria in Pregnancy Preventive
Alternative Drugs); NCT 00811421, ATM Trial Number:
ATMR2010020001429343). The three treatment arms
included three tablets of the ﬁxed combination sulphadox-
ine-pyrimethamine (500 mg/25 mg), meﬂoquine as a single
dose (15 mg/kg) or meﬂoquine as a split dose (7.5 mg/kg) on
two consecutive days. IPTp is implemented in a national
programme in Gabon and has been shown to reduce
Plasmodium falciparum infection, low birthweight and prema-
ture birth [12].
The ﬁrst dose was administered once between 13 and
28 weeks of gestation and a second dose was given at least
1 month after the ﬁrst dose [13].
Mothers were included in the S. aureus carriage substudy
after delivery of the child. Inclusion criteria were (i) partici-
pation in the MIPPAD study and (ii) delivery of a living infant.
Inclusion criteria for the MIPPAD study were (i) permanent
residence in the study area, (ii) gestational age at the ﬁrst
antenatal visit ≤28 weeks and (iii) agreement to deliver in the
study site’s maternity ward. The exclusion criterion was
serological evidence of an HIV infection. The gestational age
was assessed by measuring the symphysis–fundal height during
pregnancy and was adjusted by Ballard score at delivery.
Swabs from mothers (nasal and mammillary) and infants
(nasal and pharyngeal) were taken at delivery (visit 1), and after
1 (visit 2), 9 (visit 3) and 12 (visit 4) months and stored in
Amies transport medium at 4°C until culture within 3 days. A
questionnaire was completed on each visit addressing the
history of hospitalization, habits of breastfeeding and presence
of mastitis as deﬁned by a painful breast plus at least one of the
following symptoms: red breast, fever, stretched ﬂat nipples.
On visit 1, we recorded general demographic data and the
number of siblings at home [4].
It was common practice in the study centre to administer
amoxicillin after delivery (mother: 1 g for 5 days, infant:
250 mg for 7 days) to reduce postpartum infections.
Bacterial isolates
Swabs were cultured at the Albert Schweitzer Hospital in
Lambarene, Gabon (35°C for 24–48 h) on blood agar plates
supplemented with one Aztreonam disk (13 lg; Oxoid, Hants,
UK) [14]. Species identiﬁcation was based on colony charac-
teristics, positive catalase and an S. aureus agglutination test
(Pastorex Staph-Plus; Bio-Rad Laboratories, Marnes-la-
Coquette, France) as well as the detection of the S. aureus
speciﬁc nuc gene [15]. Species conﬁrmation and susceptibility
test were performed with VITEK2 automated systems
(bioMerieux, Marcy l’Etoile, France) using EUCAST clinical
breakpoints.
Virulence factors and S. aureus protein A (spa) types were
analysed as previously described [16]. The Based Upon Repeat
Pattern algorithm was applied to assess the clonal relatedness
of spa types with preset parameters as published [17].
Multilocus sequence typing (MLST) was performed for one
isolate of each spa type as an example [18]. The sequence
types from the MLST were clustered into clonal complexes
with EBURST using the whole MLST data set and the stringent
group deﬁnition of six of seven shared alleles (http://saureus.
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases, CMI, 20, O390–O396
CMI Schaumburg et al. Staphylococcuss aureus colonization in infancy O391
mlst.net/eburst; 06 May 2013). Each isolate was tested for
arginine catabolic mobile element (ACME) [19]. Staphylococcal
cassette chromosome mec (SCCmec) typing was performed
for all MRSA isolates [20].
Statistics
We removed duplicates of isolates if a participant was
colonized with an identical isolate (based on spa typing) at
two different sites on one visit. Mean values and standard
deviations were calculated for continuous variables. Propor-
tions were compared using chi-square test or Fisher’s exact
test where appropriate. To verify, if mothers of the three
groups (sulphadoxine-pyrimethamine, meﬂoquine full dose,
meﬂoquine split dose) could be merged in one group, we
tested if a statistically signiﬁcant difference was detectable in
the group size, age, gestational age (one-way analysis of
variance) and colonization rates (chi-square test). The OR and
95% CI were calculated to analyse associations. The signiﬁ-
cance level was 5%. Statistical analyses were performed using
‘R’, Version 2.13.1 (http://www.cran.r-project.org) and the
software-package EPICALC.
Results
In total, 311 mothers and 318 infants were included (seven
mothers delivered twins, Fig. 1). Mothers from the three IPTp
groups were comparable regarding age, gestational age and
S. aureus colonization rates and were therefore merged into
one group for further analyses (Table 1). Overall carriage rates
in mothers compared with their infants were 29.6% vs 16.4%
at birth, 40.2% vs 41.7% after 1 month, 15.7% vs 13.5% after
9 months and 19.4% vs 12.3% after 12 months, respectively.
The 1.4-fold increase of maternal colonization 1 month after
delivery and the subsequent decrease were statistically signif-
icant (p 0.009 and p <0.0005, respectively). The proportion (in
%) of nasal/pharyngeal colonization in infants was 13.1/6.6 (visit
1), 40.1/6.4 (visit 2), 12.6/4.2 (visit 3) and 10.9/4.4 (visit 4). The
proportion (in %) of maternal nasal/mammillary colonization
was 26.2/7.2 (visit 1), 36.5/6.0 (visit 2), 12.6/7.7 (visit 3) and
14.5/6.5 (visit 4).
Infant colonization after delivery (visit 1) was increased if
the mother carried S. aureus in the nose (OR = 2.2, 95% CI
1.1–4.3, p 0.015) or on the mammillae (OR = 5.1, 95% CI 1.8–
13.7, p <0.0005, Table 2). Colonization of the infant by
S. aureus was also associated with nasal and mammillary
carriage of the mother at visits 2, 3 and 4 (Table 2). All other
factors (number of siblings, age of mother, breastfeeding,
healthcare contact, IPTp) were not associated with S. aureus
colonization of the infant.
Direct transmission from mother to infant was evident in
5.6% (n = 16) when the infant was colonized with S. aureus
belonging to the same spa type as the isolate that colonized the
mother beforehand. Infant-to-mother transmission was
detected in 2.1% (n = 6). In 8% (n = 23) of mother–infant
dyads, the direction of transmission was ambiguous if both
were colonized with an isolate belonging to the same spa type
at the same time-point. To take into account the high
variability of the spa locus, we checked if the mother was
colonized with S. aureus before colonization of the child and
vice versa regardless of the spa type. Here, we found
mother-to-infant transmission in 9.2% (n = 27) and infant-to-
mother transmission in 5.1% (n = 15). The direction of
transmission was unclear in 18.1% (n = 53). An identical spa
type was found in 48.9% (n = 46) of dyads, in 6.4% (n = 6) the
spa types showed a similar repeat pattern (spa-CC 084 and
121) according to Based Upon Repeat Pattern analysis.
The proportion of participants being colonized with two
S. aureus isolates that belong to different spa types was 0–3.2%
in children and 0–3.6% in mothers throughout the study.
The proportion of permanent carriers as deﬁned by
S. aureus colonization on two consecutive visits or moreFIG. 1. Flow of participants.
TABLE 1. Characteristics of the study population
Group
p
value
Sulphadoxine-
pyrimethamine
Meﬂoquine
full dose
Meﬂoquine
split dose
Number of
mothers
110 102 99 0.4a
Age (years)  SD 24.3  6.7 24.4  6.8 25.0  7.1 0.7a
Staphylococcus aureus
colonization [%]
34.3 26.5 27.8 0.4b
Mean gestational age
(weeks)  SD
38.0  3.8 37.5  3 38.2  3.1 0.2a
aOne-way analysis of variance.
bChi-square test.
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[8,21] was 19.6% (n = 52) among mothers and 10.3% (n = 28)
among infants. The median duration of documented perma-
nent carriage (range) was 1 month (1–11) in infants and
1 month (1–12) in mothers.
The most frequent sequence type (ST) was ST15 (mothers:
30.4%, n = 78; infants: 25.1% n = 51) followed by ST152
(mothers: 25.3%, n = 65; infants: 21.7%, n = 44; Fig. 2).
Overall, the distribution of STs was similar in both groups
except for a smaller proportion of ST1 in mothers (0.8%,
n = 2, spa types: t1407, t1931) compared with infants (10.3%,
n = 22, OR = 0.06, 95% CI 0.01–0.17, p <0.0005, spa types:
t127, t1407, t1931, t7762, t8476).
In total, 460 non-duplicate S. aureus isolates were analysed;
257 were derived from mothers (nose: 206; mammillae: 44,
nose and mammillae: 7) and 203 were isolated from infants
(nose: 155, throat: 27, nose and throat: 21). Resistance was
detected against penicillin (95.2%, n = 438), oxacillin (1.9%,
n = 9), gentamicin (0.2%, n = 1), levoﬂoxacin (1.5%, n = 7),
erythromycin (4.4%, n = 20), clindamycin (1.5%, n = 5), tetra-
cycline (47.6%, n = 219) and cotrimoxazole (46.7%, n = 215).
All isolates were susceptible to glycopeptides, tigecycline,
linezolid and fosfomycin. Intake of sulphadoxine-pyrimeth-
amine as IPTp was not associated with cotrimoxazole resis-
tance (OR = 1.0, 95% CI 0.6–1.7, p 0.96). MRSA isolates
(1.9%, n = 9) were conﬁrmed by the detection of mecA and
belonged to ST5 (t653, n = 1), ST8 (t112, n = 1 and t121,
n = 3), ST45 (t437, n = 2 and t8860, n = 1) and ST88 (t4195,
n = 1). MRSA belonging to ST8 (t112 and t121) were positive
for Panton–Valentine leukocidin (PVL) and ACME and were
single-repeat variants of the spa type t008, which is also found
in the clone USA300. All PVL-positive MRSA were SCCmec
not typeable, two MRSA isolates belonging to spa type t437
harboured SCCmec V. In general, the prevalence of PVL-
positive isolates among all S. aureus was 56.7% (n = 261) and
mainly associated with ST1, ST15, ST121 and ST152 (Table 3).
Throughout the study period, ﬁve infants were hospitalized
due to suspected S. aureus infection (three skin abscesses, one
impetigo, one phlegmon) corresponding to an incidence of skin
and soft tissue infection in infants ≤12 months of age of 1572/
100 000 per year. Mastitis was reported in four cases
corresponding to an incidence of 1286/100 000 per year in
mothers within 12 months after delivery.
Discussion
In the present study we studied the maternal and infantile
S. aureus colonization in an African setting. Main ﬁndings were
TABLE 2. Maternal Staphylococcus aureus colonization as a risk factor for colonization of infants
Infant colonizationa
Visit 1 (delivery) Visit 2 (1 month) Visit 3 (9 months) Visit 4 (12 months)
Mother
colonization OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value
Nose 2.2 (1.1–4.3) 0.015 2.4 (1.4–4.3) 0.001 4.7 (1.2–16.5) 0.005 0.76 (0.01–3.8) 1
Mammillae 5.1 (1.8–13.7) <0.0005 4.2 (1.2–18.4) 0.01 13.6 (2.7–72.2) <0.0005 12.2 (2.2–67.9) <0.0005
aChi-square test and Fisher’s exact test.
FIG. 2. Pattern of multilocus sequence typing (MLST) sequence types of Staphylococcus aureus from mothers and infants.
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases, CMI, 20, O390–O396
CMI Schaumburg et al. Staphylococcuss aureus colonization in infancy O393
an increased maternal colonization 1 month after delivery, a
transmission of S. aureus from mother to the infant most likely
through the mammillae and a high prevalence of USA300-re-
lated S. aureus among MRSA isolates.
The S. aureus colonization peak in mothers 1 month after
birth is surprising as one would expect a virtually stable
colonization [2]. Other studies analysing the colonization
pattern after delivery do not conﬁrm our ﬁnding, most likely
because they did not take samples from mothers after
1 month but after 6, 4 or 2 months [4,5,7]. One might
speculate that the peak colonization is due to nosocomial
transmission after delivery or correlates with the postpartum
hormonal status. However, the postpartum drop of estrogen
levels is unlikely to explain our ﬁnding because S. aureus
colonization is positively associated with female sex hormones
or estrogen hormonal contraception [21,22].
Mammillary colonization was a risk factor for infantile
S. aureus colonization throughout the observation period and
might play an essential role in the mother-to-infant transmis-
sion of S. aureus through breastfeeding, which has also been
shown by Peacock et al. [23].
Longitudinal studies addressing the direction of transmission
between mothers and infants are rare. Some studies analysed
the concurrent colonization of mothers and infants, which is
not suitable to identify the source of transmission [24].
Jimenez-Truque et al. [5] found a vertical transmission of
identical isolates (assessed by pulsed ﬁeld gel electrophoresis)
during delivery of 0.4%, which is contrasts with our ﬁnding of
5.2% (n = 16) of mother–infant pairs being colonized with an
isolate belonging to the same spa type immediately after birth.
However, as we did not assess the antepartum colonization of
the mother, we cannot rule out a third source (e. g. nurse) for
the concurrent colonization at delivery. A mother-to-infant
transmission was evident in 5.6% (transmission of S. aureus
belonging to the same spa type) and 9.2% (S. aureus transmis-
sion independent of spa type), respectively. The low transmis-
sion rate of S. aureus isolates belonging to the same or related
spa type and a strong association of maternal and infantile
colonization suggests that infants of carrier mothers have a high
risk of also acquiring non-maternal strains. It is also possible
that infants acquired S. aureus from maternal body parts, which
might be colonized by a strain that was different from the nasal
or mammillary isolate (e. g. vaginal colonization).
A similar distribution of S. aureus STs in isolates from
mothers and infants has been reported in our study. This
ﬁnding is in line with previous reports [4]. However, the
signiﬁcantly higher proportion of S. aureus ST1 in infants is
striking. One might speculate that these isolates are more
adapted to colonize and spread in newborns as recent studies
suggest [25,26].
The classical MRSA clone USA300 (ST8/t008-MRSA-IV) is
PVL- and ACME-positive. In our collection, 44.4% (n = 4) of all
TABLE 3. Population structure and resistance proﬁle of Staphylococcus aureus from mothers and infants
CC ST (n) spa type
Antibiotic resistance (%) Virulence factors (%)
Pen Oxa Clinda Ery Tetra Cotrim
lukS-PV/
lukF-PV sea eta etb tst
CC5 ST1 (24) t127, t1407, t1931, t7762, t8476 100 0 0 0 53.3 0 66.7 37.5 0 0 25.0
ST5 (31) t002, t062, t311, t312, t319, t653, t856, t1215,
t3778, t5987
87.1 3.2 0 32.3 45.2 51.6 35.5 41.9 6.5 3.2 0
ST6 (7) t304, t701, 100 0 0 0 0 14.3 0 71.4 14.3 0 0
ST8 (22) t112, t121, t190, t1476 95.5 18.2 4.6 22.7 68.2 59.1 22.7 18.2 0 9.1 27.3
ST9 (1) t1045 100 0 0 0 100 0 0 0 0 0 0
ST15 (130) NT, t084, t094, t279, t360, t491, t963, t1492,
t2636, t7444, t8012, t8360
97.7 0 0.8 0.8 60.8 91.5 81.5 74.6 2.3 0 0
ST72 (13) t148, t537 100 0 0 0 15.4 15.4 0 7.6 0 0 0
ST94 (5) t008, t1069, t351 80 0 0 0 100 0 0 0 0 0 0
ST669 (1) t267 100 0 0 0 0 0 0 0 0 0 0
ST2434 (10) t346 100 0 0 0 40 10 20 20 80 80 0
ST2501 (8) t189 100 0 0 0 0 0 0 0 0 0 0
ST2502 (2) t2398 100 0 0 0 50 0 0 0 100 100 0
ST2618 (1) t258 100 0 0 0 100 0 0 0 0 0 0
CC30 ST30 (11) t017, t021, t1848, t8475, t8859 100 0 0 0 63.6 0 9.1 0 0 0 0
CC45 ST45 (14) t437, t4976, t8860, t10693 0 21.4 14.3 14.3 28.6 0 14.3 0 0 0 0
ST508 (25) t015, t861, t1510, t2238, t2771, t2784, t6241,
t7394, t7805, t8613, t8858, t10692
84 0 4 4 12 4 4 4 0 0 64
ST2480 (7) t939 100 0 0 0 42.9 0 0 0 0 0 0
ST2498 (3) t4576 100 0 0 0 33.3 0 0 0 0 0 0
CC88 ST88 (3) t2723, t4195 100 33.3 0 0 66.7 33.3 0 33.3 33.3 0 0
CC101 ST101 (6) t4679, t7956 100 0 0 0 83.3 0 0 16.7 0 0 0
CC121 ST121 (18) t056, t314, t940, t7763 100 0 0 0 22.2 5.6 50 0 0 0 0
CC152 ST152 (109) NT, t355, t454, t1096, t2724, t4235, t8614 91.7 0 0 0.9 56.8 55 97.3 6.4 0.9 0.9 0.9
CC707 ST707 (1) t1458 100 0 0 0 0 0 0 0 0 0 1
CC2198 ST2617 (1) t10436 100 0 0 0 0 0 0 0 0 0 0
NT NT NT, t2445, t7823, t10133 100 0 0 0 25 0 0 0 0 0 0
Singleton ST2338 (2) t6694 100 0 0 0 100 0 100 0 0 0 0
ST2492 (1) t10988 100 0 0 0 0 0 0 0 0 0 1
CC, clonal complex; ST, sequence type; Pen, penicillin; Oxa, oxacillin; Clinda, clindamycin; Ery, erythromycin; Cotrim, cotrimoxazole; lukS-PV/lukF-PV, Panton–Valentine leukocidin
(PVL); sea, staphylococcal enterotoxin A; eta, exfoliative toxin A; etb, exfoliative toxin B; tst, toxic shock syndrome toxin.
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MRSA were spa repeat variants of t008 (t112 and t121), raising
the concern of a signiﬁcant spread of this clone even in remote
African regions. So far, ST8-MRSA-IV (PVL-positive) was
reported from Cameroon and Gabon [16,27]. It remains
speculative if and to what extent the USA300 clones in Africa
and the USA are related.
The high proportion of resistance against tetracycline
(47.6%) and cotrimoxazole (46.7%) in all S. aureus isolates is
in line with other reports from sub-Saharan Africa even from
remote Pygmy populations [28,29].
The prevalence of PVL-positive isolates was high, which is in
line with recent reports of a high PVL-endemicity in Africa
[16,28–30].
The incidence of S. aureus-related skin and soft tissue
infection in infants ≤12 months old requiring hospital admis-
sion (1572/100 000 per year) is higher than in the USA (452
cases/100 000 per year) [3]. Our ﬁgure is a conservative
estimate as only hospitalized cases during a passive follow up
were included. These ﬁgures underline the public health
importance of S. aureus infections in infancy in Africa and the
interest in investigating modes of transmission.
Although our study provides valuable information on
colonization of mothers and infants in an African setting, some
limitations need to be addressed. First, the signiﬁcant number
of participants lost to follow up limits general conclusions of
the study and might be a bias towards participants with a
higher awareness of health. Second, we did not assess
pre-labour vaginal colonization, which might have played also
a signiﬁcant role in infant colonization.
In conclusion, early acquisition of S. aureus in infants is
reﬂected by a high carriage rate 1 month after delivery.
Mother-to-infant transmission was rare and cannot explain
the signiﬁcant increase of carriage rate in infants within the
ﬁrst month of life. A transmission from external sources is
therefore likely. The detection of USA300 related PVL-po-
sitive MRSA demands our attention to contain further
spread.
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